SCHEMBL3757825

SCHEMBL3757825

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3cc(N)nc(-c4cccc(C(=O)N5CC[C@H](N)C5)c4)c3)c2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 10/20 0.38
PIK3CA P42336 4/20 0.37
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CAMK1D Q8IU85 1/20 0.34
BMPR1B O00238 1/20 0.33
BMPR1A P36894 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVRL1 P37023 1/20 0.33
ACVR1 Q04771 1/20 0.33
BRAF P15056 1/20 0.33
PIK3R1 P27986 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
LRRK2 Q5S007 1/20 0.33
ATR Q13535 1/20 0.33
PLK4 O00444 1/20 0.33
JAK2 O60674 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759885 1.00 MTOR (0.38) MTORPIK3CACDK4CCND1CAMK1D
SCHEMBL3762139 0.90 MTOR (0.36) MTORPIK3CACDK4CCND1CAMK1D
SCHEMBL3763824 0.90 MTOR (0.36) MTORPIK3CACDK4CCND1CAMK1D
SCHEMBL3757676 0.90 MTOR (0.36) MTORPIK3CACDK4CCND1CAMK1D
SCHEMBL3765983 0.86 PIK3CA (0.38) MTORPIK3CABMPR1BBMPR1ATGFBR1
SCHEMBL3762352 0.85 PIK3CA (0.37) MTORPIK3CABMPR1BBMPR1ATGFBR1
SCHEMBL3762282 0.83 PIK3CA (0.41) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3766668 0.82 MTOR (0.40) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3762573 0.81 HPGD (0.46) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3761429 0.81 CBLB (0.36) MTORPIK3CACDK4CCND1BMPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA MTOR 7/4885PIK3CA 3/4885CDK4 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.